A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
about
Cefepime versus other beta-lactam antibiotics for the treatment of infections in non-neutropenic patientsCefepime versus other beta-lactam antibiotics for the treatment of infections in non-neutropenic patientsAntibiotic regimens for secondary peritonitis of gastrointestinal origin in adultsCanadian practice guidelines for surgical intra-abdominal infectionsClinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem useResults of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infectionsNew advances in the use of antimicrobial agents in surgery: intra-abdominal infections.Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study GroupNew developments and concepts in antimicrobial therapy for intra-abdominal infections.Comparison of anti-anaerobic antimicrobial strategies in cancer patients with febrile neutropenia and gastrointestinal symptoms.Antibiotic prophylaxis and treatment of surgical abdominal sepsis.Risk Models of Operative Morbidities in 16,930 Critically Ill Surgical Patients Based on a Japanese Nationwide DatabaseCombination therapy for treatment of infections with gram-negative bacteria.Neutropenic enterocolitis in adults: systematic analysis of evidence quality.Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.Comparative review of the carbapenems.Management of severe sepsis of abdominal origin.Carbapenems: a potent class of antibiotics.Cefepime: a reappraisal in an era of increasing antimicrobial resistance.Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With MetronidazoleGuidelines for the selection of anti-infective agents for complicated intra-abdominal infections.Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care.Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis.Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics.Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam.In vivo performance of antibiotic embedded electrospun PCL membranes for prevention of abdominal adhesions.The microbiology of postoperative peritonitis.
P2860
Q24200940-AB18564C-3197-4E9B-ACE7-E41F234C132EQ24242482-B516C100-1AC7-4F5C-A191-BD4797BA59CEQ24246927-33232C17-430E-42AD-9841-918EEE622A4FQ24599288-4C520272-20BF-4673-9F6A-FC3D718B9854Q28299749-91D3C8D2-599D-426C-8CC4-4B3106EC3555Q28345630-E393E14C-1C0A-4FC2-90C1-61D433D88727Q33840063-84CA0359-F7A9-4ACB-BF13-44DF130D5E86Q33980144-7DA5D74B-20FF-4648-AC30-73646895D2D2Q34028070-3C1EC046-8CA4-4E57-86FA-03C99C1DB95DQ34174170-18C26648-992F-4ECB-A6A1-D4668AD9F442Q34590022-8D2215E3-9818-42D5-99B8-E72F06A3A713Q36009346-C34D8666-0971-4ACC-A26A-9D714260BCA6Q36156077-B6085CE6-7EB0-4E79-859A-4DAA182899CAQ36157228-E4FA7BC4-3D16-4ECC-81B6-7E22083003EAQ36663656-05EE84AB-9F56-4FA5-A6BD-02E099459140Q36815085-7800735B-FBA8-4BBC-9CB3-D5A439AB6C1FQ36984156-7C860DFE-571F-4FBD-8C3A-2DF7D8FAEA44Q37030838-79EFB9D9-784D-4319-8A08-5B0EBB4D8EECQ37079350-C2CAAA6A-ECE6-46DB-8207-D70F987E3D3AQ38972381-85E91063-B930-4CC8-BC70-FC9EADD8A312Q40558538-5E264599-12AC-4F37-8991-087432A3BA9BQ43223068-7DE03BE9-2C7E-4701-9500-2F63CB0FE512Q43901109-ADD0CBE9-507D-4EBF-8D42-DCF6C975B038Q44066002-4B079BEF-849C-4FA3-A509-DD11D517DDBFQ44236347-47A11C74-90FF-41BD-BCD9-2F9A1C052ED4Q44526972-D4BEB34A-61EF-437B-B724-B9E71BEFE126Q44839684-3BB834D5-7A17-4500-83E0-759A86D1D1D2Q51118743-28CB259C-82E7-4B04-9839-C38B593BB2D8Q53993089-AFF192C4-8C7B-4BA2-BA32-304E680D1482
P2860
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A randomized, double-blind cli ...... dominal Infection Study Group.
@en
type
label
A randomized, double-blind cli ...... dominal Infection Study Group.
@en
prefLabel
A randomized, double-blind cli ...... dominal Infection Study Group.
@en
P2093
P1433
P1476
A randomized, double-blind cli ...... bdominal Infection Study Group
@en
P2093
E P Dellinger
O D Rotstein
T F Baumgartner
P304
P356
10.1001/ARCHSURG.1997.01430360040008
P577
1997-12-01T00:00:00Z